Showing results (281-290 of 361) with videos related to

Sort By:
Pageof 37
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosisHiroaki Oiwa, Keiju Aokage, Ayako Suzuki, et al.
Journal of Cancer Research and Clinical Oncology|November 2, 2015
Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinomaKakeru Hisakane, Koichi Saruwatari, Satoshi Fujii, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2025
Impact of tumor cell burden beyond the elastic layer on prognosis in T2aN0M0 non-small cell lung cancer with visceral pleural invasionKazuki Sugata, Keiju Aokage, Tetsuro Taki, et al.
Therapeutic Advances in Medical Oncology|August 1, 2020
Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancerTakahiro Ishii, Akihito Kawazoe, Akinori Sasaki, et al.
Journal of Cancer Research and Clinical Oncology|September 19, 2016
The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancerMasaki Goto, Masahito Naito, Koichi Saruwatari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2014
Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutationTatsuya Yoshida, Genichiro Ishii, Koichi Goto, et al.
Translational Lung Cancer Research|March 25, 2020
Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational studyRyutaro Kakinuma, Yukio Muramatsu, Hisao Asamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
The Impact of Molecular Subtype on Efficacy of Chemotherapy and Checkpoint Inhibition in Advanced Gastric CancerYohei Kubota, Akihito Kawazoe, Akinori Sasaki, et al.
Pageof 37